Table 1 |
||||
|
Timing of assessments |
||||
|
Baseline |
Day 1 to n |
Day n (ICU discharge) |
Hospital discharge |
|
|
|
||||
|
Inclusion/exclusion criteria |
* |
|||
|
Demographics |
* |
|||
|
APACHE II score |
* |
|||
|
SOFA score |
* |
* |
* |
|
|
TISS score |
* |
* |
||
|
Isolation |
* |
* |
* |
|
|
Steroid use |
* |
* |
* |
|
|
Antibiotic list |
* |
* |
* |
|
|
Invasive devices list |
* |
* |
* |
|
|
Colonisation data |
* |
* |
* |
|
|
Infection data |
* |
* |
* |
|
|
No. of cultures sent to laboratory |
* |
* |
* |
|
|
Adverse events |
* |
* |
||
|
Whether neighbouring patient has MRSA |
* |
* |
||
|
Standard groin swab |
* |
* |
||
|
Standard nasal swab |
* |
* |
||
|
PCR groin swab (Belfast HSCT) |
* |
|||
|
PCR nasal swab (Belfast HSCT) |
* |
|||
|
Details of wash |
* |
* |
* |
|
|
No of body wash bottles used |
* |
* |
||
|
Duration of ventilation |
* |
|||
|
ICU length of stay |
* |
|||
|
ICU survival |
* |
|||
|
Hospital length of stay |
* |
|||
|
Hospital survival |
* |
|||
|
Discharge location |
* |
|||
|
|
||||
|
APACHE II – Acute Physiological & Chronic Health Evaluation II; HSCT – Health and Social Care Trust; ICU – Intensive Care Unit; MRSA – Methicillin-resistant Staphylococcus aureus; PCR – Polymerase chain reaction; SOFA – Sequential Organ Failure Assessment; TISS – Therapeutic Intervention Scoring System; |
||||
|
Thompson et al. BMC Infectious Diseases 2008 8:161 doi:10.1186/1471-2334-8-161 |
||||